Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
PDS Biotechnology Corp (EDGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
10/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation (October 2023)"
10/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Announces Interim 24-Month Survival Rate of"
10/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Key Opinion Leader Roundtable Presentation"
10/02/2023 8-K Quarterly results
08/18/2023 8-K Quarterly results
08/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Abstract #: 55593 Abstract Title: HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation Presenter: Aaron Seo Author Block: Aaron Seo, Weihong Xiao, Olsi Gjyshi, Kyoko Court, Tatiana Cisneros Napravnik, Aradhana Venkatesan, Erica Lynn, Julie Sammouri, Lauren Colbert, Anuja Jhingran, Melissa Joyner, Lilie Lin, Maura Gillison, Ann Klopp Scientific Session Number: SS 02 Scientific Session Title: GYN 1: Integrating the Next Wave of Biomarkers for Future Gynecologic Clinical Trials Session Date/Time: October 1, 8:00AM-9:00AM"
08/14/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Announces Submission of Phase 3 Protocol to FDA to Initiate VERSATILE-003 Trial"
08/14/2023 8-K Quarterly results
Docs: "Condensed Consolidated Balance Sheets"
07/25/2023 8-K Quarterly results
07/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Abstract Title: Combining an IL-12-based Immunocytokine with Docetaxel in Metastatic Prostate Cancer: Preliminary Safety and Immune Data Paper Number: 249 Presenting Author: Head, Prostate Cancer Clinical Research Section, Ravi A. Madan Authors: Renee Donahue, Yo-Ting Tsai, Mohammad O. Atiq, Elias Chandran, Luke Meininger, Fatima Karzai, Marijo Bilusic, Jennifer Marte, Philip M. Arlen, Lisa Cordes, Megan Hausler, Amy Hankin, Nikki Williams, William D. Figg, Jeff Schlom, James L. Gulley, Ravi A. Madan Session Details: Plenary 3: Cytokines in Cancer Immunity and Immunotherapy, Mittwoch; Olympia A+B Session Date and Time: October 18, 2023, 10:00-10:15 For patients interested in enrolling in this clinical trial, please contact NCI’s toll-free number 1-800-4-Cancer and/or the Web site: https:/..."
07/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "PDS BIOTECHNOLOGY CORPORATION 2014 EQUITY INCENTIVE PLAN Adopted by the Board of Directors on May 19, 2023 THIRD AMENDED AND RESTATED PDS BIOTECHNOLOGY CORPORATION 2014 EQUITY INCENTIVE PLAN"
07/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Strengthens Intellectual Property Portfolio Governing A Combination of Versamune ® and PDS0301"
06/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation (May 2023)"
05/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
05/25/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA ® for Head and Neck Cancer Patients"
05/18/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Completes Enrollment in Immune Checkpoint Inhibitor Naïve Arm of VERSATILE-002 Phase 2 Clinical Trial in Advanced HPV16 Positive Head and Neck Cancer"
05/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation (May 2023)"
05/15/2023 8-K Quarterly results
04/27/2023 8-K Quarterly results
04/27/2023 8-K Quarterly results
04/24/2023 8-K Quarterly results
04/21/2023 8-K Quarterly results
04/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation (April 2023)"
03/28/2023 8-K Quarterly results
03/14/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation (March 2023)"
03/13/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
03/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "National Cancer Institute -led research of PDS0301, a novel investigational tumor-targeting IL-12 fusion protein, shows dose-dependent, immune responses and association with improved clinical outcomes"
02/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Completes Successful Meeting with FDA for Triple Combination of PDS0101, PDS0301 and a Commercial Immune Checkpoint Inhibitor"
02/08/2023 8-K Quarterly results
02/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
01/19/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Slide deck presentation"
01/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
12/28/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "PDS Biotech Reports Median Overall Survival of 21 Months in Advanced, Refractory Cancer Patients Having Few Remaining Treatment Options and with Reported Historical Survival of 3-4 months"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy